Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Hematology/Oncology|January 29, 2022
Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 PatientsVictor Pereira, Sabah Boudjemaa, Caroline Besson, et al.
The Laryngoscope|August 7, 2016
Pediatric salivary gland carcinomas: Diagnostic and therapeutic managementCéleste Rebours, Vincent Couloigner, Louise Galmiche, et al.
Bulletin Du Cancer|April 16, 2023
[Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma]Marie Emilie Dourthe, Mathieu Simonin, Charlotte Rigaud, et al.
Pediatric Blood & Cancer|December 2, 2021
Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescentsAurore Pire, Daniel Orbach, Louise Galmiche, et al.
Cancers|August 27, 2021
CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer PatientsPierre Verrelle, Didier Meseure, Frédérique Berger, et al.
British Journal of Haematology|February 22, 2017
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groupsAnanth G Shankar, Gaelle Roques, Amy A Kirkwood, et al.
British Journal of Haematology|February 18, 2026
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world studyMarlène Pouthier, Nathalie Garnier, Amaury Leruste, et al.
Blood Advances|June 3, 2026
​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphomaAnanth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
Hemasphere|April 22, 2026
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adultsMathieu Simonin, Mathieu Viennot, Stéphanie Haouy, et al.
The Lancet. Oncology|March 1, 2023
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration studyChristine Mauz-Körholz, Judith Landman-Parker, Ana Fernández-Teijeiro, et al.
Pageof 4